These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

197 related items for PubMed ID: 32018075

  • 1. The value of diffusion weighted imaging and apparent diffusion coefficient in primary Osteogenic and Ewing sarcomas for the monitoring of response to treatment: Initial experience.
    Asmar K, Saade C, Salman R, Saab R, Khoury NJ, Abboud M, Tamim H, Makki M, Naffaa L.
    Eur J Radiol; 2020 Mar; 124():108855. PubMed ID: 32018075
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Diffusion-weighted imaging for the differentiation of Ewing sarcoma from osteosarcoma.
    Parlak Ş, Ergen FB, Yüksel GY, Karakaya J, Aydın GB, Kösemehmetoğlu K, Aydıngöz Ü.
    Skeletal Radiol; 2021 Oct; 50(10):2023-2030. PubMed ID: 33797564
    [Abstract] [Full Text] [Related]

  • 4. Quantitative diffusion-weighted magnetic resonance imaging assessment of chemotherapy treatment response of pediatric osteosarcoma and Ewing sarcoma malignant bone tumors.
    Degnan AJ, Chung CY, Shah AJ.
    Clin Imaging; 2018 Oct; 47():9-13. PubMed ID: 28806574
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Usefulness of diffusion-weighted MRI in the initial assessment of osseous sarcomas in children and adolescents.
    Alsharief AN, Martinez-Rios C, Hopyan S, Amirabadi A, Doria AS, Greer MC.
    Pediatr Radiol; 2019 Aug; 49(9):1201-1208. PubMed ID: 31203404
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The value of diffusion-weighted imaging for monitoring the chemotherapeutic response of osteosarcoma: a comparison between average apparent diffusion coefficient and minimum apparent diffusion coefficient.
    Oka K, Yakushiji T, Sato H, Hirai T, Yamashita Y, Mizuta H.
    Skeletal Radiol; 2010 Feb; 39(2):141-6. PubMed ID: 19924412
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Diffusion-weighted imaging in differentiating mid-course responders to chemotherapy for long-bone osteosarcoma compared to the histologic response: an update.
    Habre C, Dabadie A, Loundou AD, Banos JB, Desvignes C, Pico H, Aschero A, Colavolpe N, Seiler C, Bouvier C, Peltier E, Gentet JC, Baunin C, Auquier P, Petit P.
    Pediatr Radiol; 2021 Aug; 51(9):1714-1723. PubMed ID: 33877417
    [Abstract] [Full Text] [Related]

  • 12. Prediction of Poor Responders to Neoadjuvant Chemotherapy in Patients with Osteosarcoma: Additive Value of Diffusion-Weighted MRI including Volumetric Analysis to Standard MRI at 3T.
    Lee SK, Jee WH, Jung CK, Im SA, Chung NG, Chung YG.
    PLoS One; 2020 Aug; 15(3):e0229983. PubMed ID: 32155203
    [Abstract] [Full Text] [Related]

  • 13. Percent slope analysis of dynamic magnetic resonance imaging for assessment of chemotherapy response of osteosarcoma or Ewing sarcoma: systematic review and meta-analysis.
    Kubo T, Furuta T, Johan MP, Adachi N, Ochi M.
    Skeletal Radiol; 2016 Sep; 45(9):1235-42. PubMed ID: 27229874
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Osteosarcoma: preliminary results of in vivo assessment of tumor necrosis after chemotherapy with diffusion- and perfusion-weighted magnetic resonance imaging.
    Uhl M, Saueressig U, van Buiren M, Kontny U, Niemeyer C, Köhler G, Ilyasov K, Langer M.
    Invest Radiol; 2006 Aug; 41(8):618-23. PubMed ID: 16829744
    [Abstract] [Full Text] [Related]

  • 16. Combination of 18F-FDG PET/CT and diffusion-weighted MR imaging as a predictor of histologic response to neoadjuvant chemotherapy: preliminary results in osteosarcoma.
    Byun BH, Kong CB, Lim I, Choi CW, Song WS, Cho WH, Jeon DG, Koh JS, Lee SY, Lim SM.
    J Nucl Med; 2013 Jul; 54(7):1053-9. PubMed ID: 23670899
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Monitoring Response to Neoadjuvant Chemotherapy of Primary Osteosarcoma Using Diffusion Kurtosis Magnetic Resonance Imaging: Initial Findings.
    Liu C, Xi Y, Li M, Jiao Q, Zhang H, Yang Q, Yao W.
    Korean J Radiol; 2019 May; 20(5):801-811. PubMed ID: 30993931
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Texture analysis for chemotherapy response evaluation in osteosarcoma using MR imaging.
    Baidya Kayal E, Kandasamy D, Khare K, Bakhshi S, Sharma R, Mehndiratta A.
    NMR Biomed; 2021 Feb; 34(2):e4426. PubMed ID: 33078438
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.